VEGF162, A New Heparin-binding Vascular Endothelial Growth Factor Splice Form That Is Expressed in Transformed Human Cells
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (19) , 17164-17169
- https://doi.org/10.1074/jbc.m212224200
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesisGenes & Development, 2002
- The Neuropilins Multifunctional Semaphorin and VEGF Receptors that Modulate Axon Guidance and AngiogenesisTrends in Cardiovascular Medicine, 2002
- New Isoforms of VEGF Are Translated from Alternative Initiation CUG Codons Located in Its 5′UTRBiochemical and Biophysical Research Communications, 2001
- Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variantClinical Science, 1999
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixJournal of Biological Chemistry, 1997
- Glycosylation of vascular endothelial growth factor is not required for its mitogenic activityBiochemical and Biophysical Research Communications, 1992
- Identification of the fibroblast growth factor receptor in human vascular endothelial cellsJournal of Cellular Physiology, 1988
- Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factorJournal of Cellular Physiology, 1987
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plasticCell, 1980